Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Biogen Idec's TECFIDERA™ (dimethyl fumarate) approved in US as a first-line oral treatment for multiple sclerosis
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
“Human Medicines” page
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
Brain reserve against physical disability progression over 5 years in multiple sclerosis.

Pages